ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) is the most malignant and aggressive subtype of breast cancer, which is pathologically featured by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression (1–3).